IP
NVO

Intellectus Partners’s Novo Nordisk NVO Stock Holding History

Intellectus Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.61M Buy
33,631
+9,442
+39% +$406K 0.28% 91
2026
Q1 		$918K Buy
24,189
+2,281
+10% +$108K 0.19% 138
2025
Q4 		$1.11M Buy
21,908
+9,316
+74% +$476K 0.22% 120
2025
Q3 		$699K Buy
12,592
+1,711
+16% +$100K 0.14% 172
2025
Q2 		$751K Buy
10,881
+2,149
+25% +$146K 0.16% 158
2025
Q1 		$616K Sell
8,732
-3,905
-31% -$323K 0.15% 166
2024
Q4 		$1.09M Buy
12,637
+3,753
+42% +$406K 0.24% 107
2024
Q3 		$1.06M Buy
8,884
+749
+9% +$99.9K 0.27% 111
2024
Q2 		$1.16M Sell
8,135
-200
-2% -$26.5K 0.32% 86
2024
Q1 		$1.08M Buy
8,335
+65
+0.8% +$7.74K 0.28% 102
2023
Q4 		$856K Buy
8,270
+848
+11% +$83.9K 0.25% 110
2023
Q3 		$675K Buy
+7,422
New +$654K 0.21% 134
2019
Q2 		– Sell
-112
Closed -$3K – 335
2019
Q1 		$3K Buy
+112
New +$2.75K ﹤0.01% 413

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Intellectus Partners's NVO Position: Q2 2026 in Review

Intellectus Partners increased its Novo Nordisk (NVO) stake by 39% in Q2 2026, buying an estimated $406K and bringing the position to 33,631 shares worth $1.61M. The position accounts for 0.28% of the portfolio, ranked #91.

Intellectus Partners first reported a position in NVO in Q1 2019 and has held it in 13 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Intellectus Partners held 33,631 shares of Novo Nordisk worth $1.61M as of Q2 2026.
  • Intellectus Partners bought 9,442 Novo Nordisk shares in Q2 2026, an estimated $406K.
  • Novo Nordisk made up 0.28% of Intellectus Partners's portfolio in Q2 2026, its #91 holding.
  • Intellectus Partners first reported a position in Novo Nordisk in Q1 2019 and has held it in 13 quarters since.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Intellectus Partners's 13F filing for Q2 2026, filed 12 Aug 2026.